Hi Stocksa,
I think Merck have 200 + combination trials in progress.
Not too many get podiums at top line conferences.
From what Iam told its about the next 40 patients in the Yervoy trial.
If the results continue to positive I think its a rerate.Maybe $2 imo.
Aloha.
Add to My Watchlist
What is My Watchlist?